Perspectives and challenges of clinical pharmacogenomics in cancer

Pharmacogenomics. 2004 Jul;5(5):451-4. doi: 10.1517/14622416.5.5.451.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Clinical Trials as Topic / methods
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Pharmacogenetics / methods*

Substances

  • Biomarkers, Tumor